# EDGAR Filing Document

**Accession Number:** 0001714585
**File Stem:** 0001062993-23-006279
**Filing Date:** 2023-3
**Character Count:** 8813
**Document Hash:** 1e977f4c05839b3fa0179e478f117514
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001062993-23-006279.hdr.sgml**: 20230308

**ACCESSION NUMBER**: 0001062993-23-006279

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230306

**FILED AS OF DATE**: 20230308

**DATE AS OF CHANGE**: 20230308

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Stellato Paul A
- **CENTRAL INDEX KEY:** 0001714585

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-16407
- **FILM NUMBER:** 23716434

**MAIL ADDRESS:**
- **STREET 1:** C/O XYLEM INC
- **STREET 2:** 1 INTERNATIONAL DRIVE
- **CITY:** RYE BROOK
- **STATE:** NY
- **ZIP:** 10573
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ZIMMER BIOMET HOLDINGS, INC.
- **CENTRAL INDEX KEY:** 0001136869
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **IRS NUMBER:** 134151777
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 345 EAST MAIN STREET
- **CITY:** WARSAW
- **STATE:** IN
- **ZIP:** 46580
- **BUSINESS PHONE:** 5742676131

**MAIL ADDRESS:**
- **STREET 1:** 345 EAST MAIN STREET
- **CITY:** WARSAW
- **STATE:** IN
- **ZIP:** 46580

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ZIMMER HOLDINGS INC
- **DATE OF NAME CHANGE:** 20010315

## Ex-24

```

POWER OF ATTORNEY

For Executing Forms 3, 4, 5 and 144

     The undersigned hereby constitutes and appoints
each of Chad Phipps, Matthew R. St. Louis and Laura
Flavin, signing singly, as the undersigned's true
and lawful attorney-in-fact, for such period of
time that the undersigned is required to file
reports pursuant to Section 16(a) of the
Securities Exchange Act of 1934, as amended
the "Exchange Act"), or Rule 144
of the Securities Act of 1933, as amended (the
"Securities Act"), due to the undersigned's
affiliation with Zimmer Biomet Holdings, Inc.,
a Delaware corporation, unless earlier revoked
by the undersigned in a signed writing delivered
to the foregoing attorneys-in-fact, to:

1) execute for and on behalf of the undersigned
Form ID, Forms 3, 4, 5 and 144 and any amendments
to previously filed forms in accordance with
Section 16(a) of the Exchange Act or Rule 144 of the
Securities Act and the rules thereunder;

2) do and perform any and all acts for and on
behalf of the undersigned which may be necessary
or desirable to complete the execution of any such
Form ID, Forms 3, 4, 5 and 144 and the timely filing
of such form with the United States Securities and
Exchange Commission and any other authority as
required by law; and

3) take any other action of any type whatsoever in
connection with the foregoing which, in the opinion
of such attorney-in-fact, may be of benefit to, in
the best interest of or legally required by the
undersigned, it being understood that the
documents executed by such attorney-in-fact on
behalf of the undersigned pursuant to this Power
of Attorney shall be in such form and shall
contain such terms and conditions as such
attorney-in-fact may approve in such attorney-
in-fact's discretion.

     The undersigned hereby grants to each such
attorney-in-fact full power and authority to do
and perform all and every act and thing whatsoever
requisite, necessary and proper to be done in
the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes
as
the undersigned could do if personally present,
with full power of substitution or revocation,
hereby ratifying and confirming all that such
attorney-in-fact, or the attorney-in-fact's
substitute or substitutes, shall lawfully do or
cause to be done by virtue of this Power of
Attorney and the rights and powers herein granted.
The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at
the request of the undersigned, are not assuming
any of the undersigned's responsibilities to
comply with Section 16 of the Exchange Act or
Rule 144 of the Securities Act.

     IN WITNESS WHEREOF, the undersigned has
caused this Power of Attorney to be executed
as of this 20th day of May, 2022.

/s/ Paul A. Stellato
Paul A. Stellato

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Stellato Paul A<br><sub>(Last) (First) (Middle)</sub><br>345 E. MAIN STREET<br><sub>(Street)</sub><br>WARSAW, IN 46580<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-06 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_VP, Controller & CAO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>ZIMMER BIOMET HOLDINGS, INC. [ ZBH ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(1)</sup> | 2023-03-06 |  | A |  | 1824 |  | <sup>(2)</sup> | <sup>(2)</sup> | Common Stock | 1824 | $0 | 1824 | D |  |

---

### Footnotes:

(1) Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

(2) Vests annually over three years in increments of one-third each year, commencing March 6, 2024.

**Remarks:**
Exhibit 24 - Power of Attorney

**Signature:** /s/ Matthew R. St. Louis,  Attorney-in-Fact for Paul A. Stellato (power of attorney attached hereto)  
**Date:** 2023-03-08

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**